← All claims

Sweeteners · Diets

aspartame worsens phenylalanine control in phenylketonuria

Strong support Sweeteners

Part of: • aspartame

RefutedContestedStrong support
consensus score 0.71

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Population patterns (Observational)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

7 support 0 contradict 0 tested null 1 mixed · 8 sources, 7 independent groups

What the evidence shows

True and regulatorily mandated: aspartame metabolizes to phenylalanine, so people with phenylketonuria (who cannot metabolize phenylalanine) must count or avoid it — hence the FDA-required 'contains phenylalanine' warning label. Note the scope: this is a specific contraindication for PKU patients.

The evidence (8)

SourceGradeStanceQualityFinding
Butchko et al.
2002 · Regul Toxicol Pharmacol
observational supports moderate Comprehensive safety review: aspartame safe for the general population, but PKU individuals must restrict it as a phenylalanine source.
Opladen T et al
1993 · University of Washington, Seattle, Seattle (WA)
observational supports moderate Clinical management guidance for PTS-related tetrahydrobiopterin deficiency (a PAH-pathway hyperphenylalaninemia disorder managed like PKU with Phe-restricted diet) states persons on a Phe-reduced diet should avoid aspartame-containing prod
Trefz et al.
1994
RCT mixed moderate PKU heterozygotes (carriers): high-dose aspartame raised plasma Phe within normal range, no cognitive/EEG effect — carriers tolerate it; restriction applies to PKU homozygotes.
Council on Scientific Affairs
1985 · JAMA
observational supports moderate AMA Council on Scientific Affairs: individuals controlling phenylalanine intake must handle aspartame as any other phenylalanine source.
Maler V et al
2023 · study_type: observational
observational supports moderate Analysis of 401 aspartame/Phe-containing drugs marketed in France found significant (medium/high, >10 mg/day) Phe intake from about half of aspartame-containing medications, concluding PKU patients on Phe-restricted diets should avoid or ac
Garriga & Metcalfe
1988
observational supports low Aspartame contains phenylalanine; FDA mandates a PKU warning label on aspartame-containing products.
van Vliet et al.
2020 · Nutrients
in-vitro supports high LC-MS/MS of 111 soft drinks: aspartame delivers variable, often-undeclared phenylalanine loads — PKU patients advised to avoid.
Öncel HU et al
2026 · study_type: observational
observational supports low Narrative safety review of aspartame notes that phenylalanine liberated from aspartame metabolism affects brain development, and states that consumption levels should be more closely monitored in special risk groups including PKU patients.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.